HLA-C and KIR permutations influence chronic obstructive pulmonary disease risk-Reference-Cited by-同舟云学术

HLA-C and KIR permutations influence chronic obstructive pulmonary disease risk

Published:2021-10-08 Issue:19 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Mkorombindo Takudzwa^ORCID,Tran-Nguyen Thi K.^ORCID,Yuan Kaiyu,Zhang Yingze^ORCID,Xue Jianmin,Criner Gerard J.^ORCID,Kim Young-il,Pilewski Joseph M.^ORCID,Gaggar Amit,Cho Michael H.^ORCID,Sciurba Frank C.^ORCID,Duncan Steven R.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/150187/files/pdf

Reference43 articles.

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019

2. Familial Correlation in the Decline of Forced Expiratory Volume in One Second

3. Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction

4. Network medicine approaches to the genetics of complex diseases;Silverman;Discov Med,2012

5. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning Reveals Impacts of Smoking on Gene Profiles of Different Cell Types in Lung;Life;2024-04-13

2. Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?;Cancers;2024-03-22

3. Identification of molecular subtypes and immune infiltration in endometriosis: a novel bioinformatics analysis and In vitro validation;Frontiers in Immunology;2023-08-18

4. Associations of Smoking, Cytomegalovirus Serostatus, and Natural Killer Cell Phenotypes in Smokers With and At Risk for COPD;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2023

5. Immunity at maternal–fetal interface:KIR/HLA(Allo)recognition*;Immunological Reviews;2022-05-24